Skip to main content

Main navigation

  • About
    • Members
    • Our Team
    • Annual Report
    • Rutgers-NPC Health Policy & Communications Fellowship
    • NPC Summer Scholars
    • Contact Us
  • Topics
    • Health Spending
      • IRA & Medicare Drug Price Negotiation
      • 340B Drug Pricing Program
      • Understanding Health Spending
      • Low-Value Care
      • Health Spend Management
    • Value Assessment
      • Value Assessment Frameworks
      • Value Assessment Methods
      • Elements of Value
    • Alternative Payment Models
      • Value-Based Contracts
      • Regulatory Barriers & Challenges
      • Paying for Cures
      • Accountable Care Organizations
      • Bundled Payments
      • Health Care Quality Measures
      • Clinical Pathways
    • Patient-Centered Formulary & Benefit Design
      • High-Deductible Health Plans
      • Value-Based Insurance Design
      • Utilization Management & Step Therapy
      • Formulary Development
      • Patient Cost Sharing
      • Individual Treatment Effects & Personalized Access
    • Evidence for Decision Making
      • Real-World Data
      • Real-World Evidence
      • Good Practices for Evidence
    • Biopharma Innovation
      • Impact on Outcomes & Spending
  • Resources
    • Research
    • Fact Sheets
    • Policy & Evidence Briefs
    • Letters & Comments
    • E.V.I.dently Today Blog
    • Newsletters
    • Events
    • CER Daily Newsfeed®
    • Press Room
      • NPC in the News
      • NPC Press Releases
    • Videos and Graphics
    • Stakeholder Resources
      • For Employers
      • For Patient Organizations
      • Going Below The Surface
  • Get Involved
    • Become a Member
    • Submit a Research Proposal
    • Start a Career
National Pharmaceutical Council

Offscreen menu

User account menu

  • Member Resources

Little Consistency in Evidence Cited by Commercial Health Plans for Specialty Drug Coverage

  • Read more about Little Consistency in Evidence Cited by Commercial Health Plans for Specialty Drug Coverage

Fifth Annual Survey on CER & Health Care Decision-Making: What Can We Expect This Year?

  • Read more about Fifth Annual Survey on CER & Health Care Decision-Making: What Can We Expect This Year?

NPC’s Dr. Jennifer Graff Testifies Before FDA on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Devices

  • Read more about NPC’s Dr. Jennifer Graff Testifies Before FDA on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Devices

Pre-Approval Information Exchange Can Help Improve Population Health Decision-Making

  • Read more about Pre-Approval Information Exchange Can Help Improve Population Health Decision-Making

FDA Releases Guidance Documents on Communicating Clinical and Economic Information

  • Read more about FDA Releases Guidance Documents on Communicating Clinical and Economic Information

NPC Submits Comments to FDA on Exchange of Clinical and Economic Information

  • Read more about NPC Submits Comments to FDA on Exchange of Clinical and Economic Information

How Are Health Plans Using Patient Data to Improve Outcomes?

  • Read more about How Are Health Plans Using Patient Data to Improve Outcomes?

NPC @ DIA 2017 Annual Meeting: Exploring Comparative Effectiveness Research

  • Read more about NPC @ DIA 2017 Annual Meeting: Exploring Comparative Effectiveness Research

CER Collaborative Helps Health Care Decision-Makers Assess Evidence

  • Read more about CER Collaborative Helps Health Care Decision-Makers Assess Evidence

What Kinds of Information Do Payers and Providers Want for Decision-Making?

  • Read more about What Kinds of Information Do Payers and Providers Want for Decision-Making?

Pagination

  • Next page
  • Page 3
  • Next page
Subscribe to Evidence for Decision Making

Let's stay in touch.

Subscribe to our newsletter.
© 2026 NPC. All rights reserved.

Footer Menu

  • Accessibility
  • Privacy Policy
  • Terms of Use
  • Contact Us

Footer Social Links Menu

  • Twitter image/svg+xml
  • Linkedin
  • Youtube